 |
Editors:
Andrew Freese (Minneapolis, MN)
Frederick A. Simeone (Philadelphia, PA)
Paola Leone (Camden, NJ)
Christopher Janson (Camden, NJ)
|
The future of neurosurgery will be characterized by less invasive, molecular technologies that promise to revolutionize the field of neurosurgery and impact the treatment of additional neurological disorders, including neurometabolic diseases, stroke, dementias, affective and psychiatric diseases, movement disorders, epilepsy, and others.
This book encompasses developing an understanding of the principles underlying the advent of novel molecular approaches to neurological and neurosurgical diseases. It identifies key principles that will allow dramatic improvement in the treatment and outcomes of patients suffering from a variety of disorders affecting the central nervous system and spinal axis.
This volume gives neurosurgeons an excellent understanding of the development of novel molecular and cellular technologies that will markedly change the way neurosurgery is practiced in the near future. It is also of special interest to neurologists, psychiatrists, physiatrists, spinal orthopaedic surgeons, neurobiologists and gene therapy research scientists.
